SEC Form 5 · accession 0001104659-18-074495
Decoy Therapeutics Inc. · DCOY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christoph H Westphal
10% Owner
Period of report
Dec 31, 2017
Accepted (ET)
Dec 21, 2018 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 6, 2018 | G | 858,300 | $0.00 | D | 3,044,627 | D | |
| Common Stock | Dec 20, 2018 | G | 2,200,000 | $0.00 | D | 844,627 | D | |
| Common StockF1 | holding | — | — | — | 22,321 | D | ||
| Common StockF2 | holding | — | — | — | 15,870 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held directly by The Christoph H. Westphal Revocable Trust, the Reporting Person is a beneficiary of The Christoph H. Westphal Revocable Trust.
- F2These shares are held directly by The Christoph Westphal Roth IRA, the Reporting Person is a beneficiary of The Christoph Westphal Roth IRA.